Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday, ...

After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot ...

The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...

Former Harvard University President Larry Summers last fall stopped teaching classes there after fallout from his dealings ...

Scientific publishing relies on peer review as the mechanism that maintains trust in what we publish. When we read a journal article, we assume experts have rigorously scrutinized it before ...

On a frigid Norwegian afternoon earlier this month, Dan Quintana, a psychology professor at the University of Oslo, decided to stay in and complete a tedious task that he had been putting off for ...

Yale removes Professor David Gelernter from class amid review over Jeffrey Epstein emails.

An exclusive conversation with Kevin Weil, head of OpenAI for Science, a new in-house team that wants to make scientists more productive. In the three years since ChatGPT’s explosive debut, OpenAI’s ...

Prism is a ChatGPT-powered text editor that automates much of the work involved in writing scientific papers. OpenAI just revealed what its new in-house team, OpenAI for Science, has been up to. The ...

NASA has selected two Earth science missions for development, one focused on studying the atmosphere and the other on terrestrial ecosystems and ice.

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...